Human ferritin cages for imaging vascular macrophages

Biomaterials

Volumn 32, Issue 5, 2011, Pages 1430-1437

  Terashima, Masahiro ^a   Uchida, Masaki ^b   Kosuge, Hisanori ^a   Tsao, Philip S ^a   Young, Mark J ^b   Conolly, Steven M ^c   Douglas, Trevor ^b   McConnell, Michael V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c University of California at Berkeley   (United States)

Author keywords

Atherosclerosis; Ferritin; Inflammation; Macrophage; Molecular imaging; Nanoparticle

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; FERRITIN; HUMAN ATHEROSCLEROTIC PLAQUES; HUMAN FERRITIN; IMAGING AGENT; IN-VIVO; INFLAMMATION; KEY COMPONENT; MAGNETITE NANOPARTICLES; MOLECULAR IMAGING; TARGET DELIVERY; TRANSPORT PROTEINS;

DISEASES; FLUORESCENCE; IRON ORES; MACROPHAGES; NANOMAGNETICS; NANOPARTICLES; PATHOLOGY; RESONANCE;

MAGNETIC RESONANCE IMAGING;

FERRITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ATHEROSCLEROSIS; EX VIVO STUDY; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; CARBOCYANINES; FERRITINS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MODELS, THEORETICAL; PLAQUE, ATHEROSCLEROTIC;

MURINAE;

EID: 78649731248     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.029     Document Type: Article

References (39)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
2. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8(10):802-815.
3. Osborn E.A., Jaffer F.A. Advances in molecular imaging of atherosclerotic vascular disease. Curr Opin Cardiol 2008, 23(6):620-628.
4. Jaffer F.A., Weissleder R. Molecular imaging in the clinical arena. JAMA-J Am Med Assoc. 2005, 293(7):855-862.
5. Nahrendorf M., Sosnovik D.E., Weissleder R. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 2008, 103(2):87-94.
6. Korosoglou G., Weiss R.G., Kedziorek D.A., Walczak P., Gilson W.D., Schar M., et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol 2008, 52(6):483-491.
7. Deguchi J., Aikawa M., Tung C.H., Aikawa E., Kim D.E., Ntziachristos V., et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006, 114(1):55-62.
8. Kaufmann B.A., Sanders J.M., Davis C., Xie A., Aldred P., Sarembock I.J., et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007, 116(3):276-284.
9. Tahara N., Kai H., Yamagishi S., Mizoguchi M., Nakaura H., Ishibashi M., et al. Vascular inflammation evaluated by [F-18]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007, 49(14):1533-1539.
10. Rudd J.H., Hyafil F., Fayad Z.A. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(7):1009-1016.
11. Yang X.M. Nano- and microparticle-based imaging of cardiovascular interventions: overview. Radiology 2007, 243(2):340-347.
12. Allen M., Bulte J.W.M., Liepold L., Basu G., Zywicke H.A., Frank J.A., et al. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 2005, 54(4):807-812.
13. Liepold L., Anderson S., Willits D., Oltrogge L., Frank J.A., Douglas T., et al. Viral capcids as MRI contrast agents. Magn Reson Med 2007, 58:871-879.
14. Hooker J.M., Datta A., Botta M., Raymond K.N., Francis M.B. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett 2007, 7(8):2207-2210.
15. Anderson E.A., Isaacman S., Peabody D.S., Wang E.Y., Canary J.W., Kirshenbaum K. Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 2006, 6(6):1160-1164.
16. Lewis J.D., Destito G., Zijlstra A., Gonzalez M.J., Quigley J.P., Manchester M., et al. Viral nanoparticles as tools for intravital vascular imaging. Nat Med 2006, 12(3):354-360.
17. Aime S., Frullano L., Crich S.G. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed Engl 2002, 41(6):1017-1019.
18. Uchida M., Flenniken M.L., Allen M., Willits D.A., Crowley B.E., Brumfield S., et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 2006, 128(51):16626-16633.
19. Uchida M., Terashima M., Cunningham C.H., Suzuki Y., Willits D.A., Willis A.F., et al. A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 2008, 60(5):1073-1081.
20. Flenniken M.L., Willits D.A., Brumfield S., Young M., Douglas T. The small heat shock protein cage from methanococcus jannaschii is a versatile nanoscale platform for genetic and chemical modification. Nano Lett 2003, 3(11):1573-1576.
21. Liepold L.O., Abedin M.J., Buckhouse E.D., Frank J.A., Young M.J., Douglas T. Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett 2009, 9(12):4520-4526.
22. Pang J.H.S., Jiang M.J., Chen Y.L., Wang F.W., Wang D.L., Chu S.H., et al. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 1996, 97(10):2204-2212.
23. Yuan X.M. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Radic Res 1999, 30(3):221-231.
24. Li W., Xu L.H., Forssell C., Sullivan J.L., Yuan X.M. Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques. Exp Biol Med 2008, 233(7):818-826.
25. Recalcati S., Invernizzi P., Arosio P., Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 2008, 30(1-2):84-89.
26. Fisher J., Devraj K., Ingram J., Slagle-Webb B., Madhankumar A.B., Liu X., et al. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol-Cell Physiol 2007, 293(2):C641-C649.
27. Todorich B., Zhang X.S., Slagle-Webb B., Seaman W.E., Connor J.R. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 2008, 107(6):1495-1505.
28. Sawyer R.T., Day B.J., Fadok V.A., Chiarappa-Zucca M., Maier L.A., Fontenot A.P., et al. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol 2004, 31(4):470-477.
29. Theil E.C. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987, 56:289-315.
30. Harrison P.M., Arosio P. Ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275(3):161-203.
31. Lichtman A.H., Clinton S.K., Iiyama K., Connelly P.W., Libby P., Cybulsky M.I. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 1999, 19(8):1938-1944.
32. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193(4251):415-417.
33. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997, 17(10):2238-2244.
34. Levenson R.M., Mansfield J.R. Multispectral imaging in biology and medicine: slices of life. Cytometry A 2006, 69A(8):748-758.
35. Waldeck J., Hager F., Holtke C., Lanckohr C., von Wallbrunn A., Torsello G., et al. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alpha(v)beta(3) integrin-targeted fluorochrome. J Nucl Med 2008, 49(11):1845-1851.
36. Nahrendorf M., Zhang H.W., Hembrador S., Panizzi P., Sosnovik D.E., Aikawa E., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117(3):379-387.
37. Ntziachristos V., Ripoll J., Wang L.H.V., Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotech 2005, 23(3):313-320.
38. Cunningham C.H., Arai T., Yang P.C., McConnell M.V., Pauly J.M., Conolly S.M. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005, 53(5):999-1005.
39. Pan D., Caruthers S.D., Hu G., Senpan A., Scott M.J., Gaffney P.J., et al. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. J Am Chem Soc 2008, 130(29):9186-9187.